Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Nurses Are “Critical Link” in Providing Patients With Education and Empathy

      April 9, 2024
      By Alex Biese
      News
      Article
      Oncology Nursing NewsApril 2024
      Volume 18
      Issue 2

      Oncology nurses provide patients with lung cancer the education and empathy needed to navigate treatment options and adverse event management.

      Women doctors smiling together in the hospital: © Laura - stock.adobe.com

      Women doctors smiling together in the hospital: © Laura - stock.adobe.com

      Oncology nurses can provide empathy and education as the “critical link” for individuals with lung cancer via patient-centered care, Lisa Carter Bawa, PhD, MPH, APRN, ANP-C, FAAN, explains.

      "We think we might know best, but when you really come into a health care encounter with [a mindset of] patient-centered care, you are open to listening to the patient, thinking outside the box [in a way] that might be specific to that patient, and really focusing on what they are dealing with,” said Carter-Bawa, director of the Cancer Prevention Precision Control Institute at the Center for Discovery and Innovation at Hackensack Meridian Health in New Jersey.

      “Ultimately, if a patient who’s diagnosed with cancer…is on a specific treatment regimen, if you engage that patient and develop that patient relationship, and you approach it from a perspective of patient-centered care, you’re going to have patients who adhere to their treatment and have better outcomes because they’re following the regimen that they, as well as their clinician, have decided is the best course of action for them,” said Carter-Bawa.

      For example, immunotherapies have emerged as a significant treatment option for patients with lung cancer, with such drugs—including the immune checkpoint inhibitors pembrolizumab (Keytruda), atezolizumab (Tecentriq), and nivolumab (Opdivo)—harnessing the body’s immune system to treat the disease. These treatments, in turn, can lead to various adverse effects and these effects, Carter-Bawa said, include fatigue; skin rash; gastrointestinal disturbances; flu-like symptoms such as fever, chills, and muscle pain; inflammation of the lungs; and thyroid dysfunction.

      “[These drugs] actually block the interaction between the proteins on the immune cells as well as the cancer cells, which, in turn, lowers the immune system’s response to the cancer. That said, that’s actually where we get the [adverse] effects,” Carter-Bawa explained.

      Oncology nurses, Carter-Bawa said, serve as educators and provide comprehensive information about treatment regimens and potential adverse effects to patients and their families. This includes guidance on symptom recognition, when to seek medical care, and strategies for managing adverse effects through dietary adjustments, medication management, and lifestyle modifications.

      Moreover, nurses continuously monitor patients throughout their treatment journey, assessing vital signs, reviewing lab results, and actively listening to patients’ concerns to identify any changes or emerging issues. By offering emotional support, nurses empower patients to cope effectively with the challenges they face, fostering a sense of reassurance and resilience.

      “I always think of nursing as getting this right, but I think it’s even more prominent now that there’s been an increased emphasis on patient-centered care, which really prioritizes addressing the individual needs, preferences, and goals of the patient and their family,” Carter-Bawa said. “And nurses receive continuing education training…to provide this personalized education specific to these different regimens, as well as support that helps them to tailor [education] to the patient’s specific circumstances, which ultimately has the potential to enhance the quality of life and the quality of symptom management for their patients.”

      Download Issue PDF
      Articles in this issue

      Medical center unique design kit for social networks stories. Online medical assistance service mobile screen templates for app. UI UX layouts vector illustration. GUI set with people characters: © alexdndz - stock.adobe.com
      Recognition of the Advanced Practice Preceptor Role in Oncology
      Doctor, laptop and neck pain at night in agony, stressed or burnout by desk at the hospital. Woman medical professional suffering from painful injury, ache or inflammation working late on computer - © C Malambo/peopleimages.com - stock.adobe.com
      Embracing Vicarious Resilience in Oncology Nursing: A Light in the Dark
      Women doctors smiling together in the hospital: © Laura - stock.adobe.com
      Nurses Are “Critical Link” in Providing Patients With Education and Empathy
      Knowledge of Risk Factors, Treatment Options Are Key to Managing Bladder Cancer
      Knowledge of Risk Factors, Treatment Options Are Key to Managing Bladder Cancer
      Confident doctor and woman patient discuss test results on pad screen on appointment at oncological center. Qualified physician explain treatment plan to young female sick with cancer using tablet pc: © fizkes - stock.adobe.com
      The Importance of Quality of Life in Bladder Cancer
      Prostate cancer. Urologist examines male genitourinary system. Diagnosis of prostatitis or sexual dysfunction. Andrologist engaged in prevention and treatment of prostate gland diseases: © buravleva_stock - stock.adobe.com
      Bladder-Preserving Options in Bladder Cancer

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Image of a woman with gray hair on a light blue background
      Photo of a man wearing scrubs in front of a blue background
      Cancer-Related Cognitive Impairment
      Related Content

      The FDA granted fast track designation to ZL-1310 to treat patients with extensive-stage small cell lung cancer.

      FDA Grants Fast Track Designation to ZL-1310 in Extensive Stage SCLC

      Courtney Flaherty
      May 20th 2025
      Article

      The agent is currently being evaluated as both monotherapy and in combination with atezolizumab in patients with extensive stage SCLC in an ongoing, global phase 1 trial.


      The Vitals

      Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

      Lindsay Fischer
      November 15th 2023
      Podcast

      Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.


      Graphic reading "FDA Approved" resembling an approval stamp

      Telisotuzumab Vedotin-tllv Given Accelerated Approval for NSCLC

      Bridget Hoyt
      Published: May 14th 2025 | Updated: May 16th 2025
      Article

      Telisotuzumab vedotin-tllv has earned accelerated approval for use in patients with non-squamous non-small cell lung cancer with high c-Met overexpression.


      Oncology Nursing News

      A Look Back at 2022 FDA Approvals in Oncology

      Oncology Nursing News
      January 2nd 2023
      Podcast

      In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.


      Anatomical image of a person with a tumor in their left lung

      Lurbinectedin Plus Pembrolizumab May Yield Activity in Relapsed SCLC

      Russ Conroy
      May 5th 2025
      Article

      Early-phase LUPER trial results suggest the lurbinectedin/pembrolizumab combination may benefit patients with relapsed small cell lung cancer.


      Anatomical image of a person with a tumor on their lung

      First-Line Adagrasib Active in STK11/KRAS G12C–Mutated NSCLC

      Jordyn Sava
      May 4th 2025
      Article

      Adagrasib shows early signs of activity and tolerability in patients with STK11/KRAS G12C–mutated non–small cell lung cancer.

      Related Content

      The FDA granted fast track designation to ZL-1310 to treat patients with extensive-stage small cell lung cancer.

      FDA Grants Fast Track Designation to ZL-1310 in Extensive Stage SCLC

      Courtney Flaherty
      May 20th 2025
      Article

      The agent is currently being evaluated as both monotherapy and in combination with atezolizumab in patients with extensive stage SCLC in an ongoing, global phase 1 trial.


      The Vitals

      Nicole Gay Shares How She Counsels Patients on Lung Cancer Screenings

      Lindsay Fischer
      November 15th 2023
      Podcast

      Nicole Gay, APRN-C, shares how nurse navigators can talk to their patients about lung cancer screening.


      Graphic reading "FDA Approved" resembling an approval stamp

      Telisotuzumab Vedotin-tllv Given Accelerated Approval for NSCLC

      Bridget Hoyt
      Published: May 14th 2025 | Updated: May 16th 2025
      Article

      Telisotuzumab vedotin-tllv has earned accelerated approval for use in patients with non-squamous non-small cell lung cancer with high c-Met overexpression.


      Oncology Nursing News

      A Look Back at 2022 FDA Approvals in Oncology

      Oncology Nursing News
      January 2nd 2023
      Podcast

      In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.


      Anatomical image of a person with a tumor in their left lung

      Lurbinectedin Plus Pembrolizumab May Yield Activity in Relapsed SCLC

      Russ Conroy
      May 5th 2025
      Article

      Early-phase LUPER trial results suggest the lurbinectedin/pembrolizumab combination may benefit patients with relapsed small cell lung cancer.


      Anatomical image of a person with a tumor on their lung

      First-Line Adagrasib Active in STK11/KRAS G12C–Mutated NSCLC

      Jordyn Sava
      May 4th 2025
      Article

      Adagrasib shows early signs of activity and tolerability in patients with STK11/KRAS G12C–mutated non–small cell lung cancer.

      Latest Conference Coverage

      Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R/R Myeloma

      Acupuncture Use in BC Predicted by Social Determinants of Health

      Variability Found in PROs, Gene Expression During AML Induction Chemo

      Blinatumomab-Linked ICANS Cases Higher Than Previously Reported

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.